| 发明名称 |
CARDIO- AND RENOPROTECTIVE ANTIDIABETIC THERAPY |
| 摘要 |
The present invention relates to a certain DPP-4 inhibitor for use in cardio- and/or renoprotective therapy, including in patients at high vascular risk. |
| 申请公布号 |
US2014274889(A1) |
申请公布日期 |
2014.09.18 |
| 申请号 |
US201414210801 |
申请日期 |
2014.03.14 |
| 申请人 |
JOHANSEN Odd-Erik;VON EYNATTEN Maximilian;KLEIN Thomas;WOERLE Hans-Juergen |
发明人 |
JOHANSEN Odd-Erik;VON EYNATTEN Maximilian;KLEIN Thomas;WOERLE Hans-Juergen |
| 分类号 |
A61K31/522;A61K45/06 |
主分类号 |
A61K31/522 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method of using linagliptin, or a pharmaceutically acceptable salt thereof, in therapy of a patient having or being at-risk of cardiovascular and/or renal microvascular disease, the method comprising administering linagliptin, or a pharmaceutically acceptable salt thereof, optionally in combination with one or more other active agents, to said patient |
| 地址 |
Hoevik NO |
